nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetohydroxamic Acid—Deep vein thrombosis—Fludarabine—lymphatic system cancer	0.0472	0.0472	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Mechlorethamine—lymphatic system cancer	0.0371	0.0371	CcSEcCtD
Acetohydroxamic Acid—Haemolytic anaemia—Mechlorethamine—lymphatic system cancer	0.0356	0.0356	CcSEcCtD
Acetohydroxamic Acid—Haemolytic anaemia—Teniposide—lymphatic system cancer	0.0262	0.0262	CcSEcCtD
Acetohydroxamic Acid—Depression—Mechlorethamine—lymphatic system cancer	0.0247	0.0247	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Mechlorethamine—lymphatic system cancer	0.0196	0.0196	CcSEcCtD
Acetohydroxamic Acid—Injury—Bleomycin—lymphatic system cancer	0.0166	0.0166	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Fludarabine—lymphatic system cancer	0.0158	0.0158	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Carmustine—lymphatic system cancer	0.0154	0.0154	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Mechlorethamine—lymphatic system cancer	0.0151	0.0151	CcSEcCtD
Acetohydroxamic Acid—Injury—Carmustine—lymphatic system cancer	0.0145	0.0145	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Teniposide—lymphatic system cancer	0.0145	0.0145	CcSEcCtD
Acetohydroxamic Acid—Deep vein thrombosis—Methotrexate—lymphatic system cancer	0.014	0.014	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.0137	0.0137	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Teniposide—lymphatic system cancer	0.0132	0.0132	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Fludarabine—lymphatic system cancer	0.0127	0.0127	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Fludarabine—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Acetohydroxamic Acid—Malaise—Fludarabine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Teniposide—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Fludarabine—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Acetohydroxamic Acid—Depression—Carmustine—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Teniposide—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Carmustine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Mechlorethamine—lymphatic system cancer	0.01	0.01	CcSEcCtD
Acetohydroxamic Acid—Rash—Mechlorethamine—lymphatic system cancer	0.00996	0.00996	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00995	0.00995	CcSEcCtD
Acetohydroxamic Acid—Depression—Vincristine—lymphatic system cancer	0.00978	0.00978	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Fludarabine—lymphatic system cancer	0.00976	0.00976	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Teniposide—lymphatic system cancer	0.0096	0.0096	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Mitoxantrone—lymphatic system cancer	0.00939	0.00939	CcSEcCtD
Acetohydroxamic Acid—Nausea—Mechlorethamine—lymphatic system cancer	0.00938	0.00938	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Bleomycin—lymphatic system cancer	0.00933	0.00933	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Fludarabine—lymphatic system cancer	0.0089	0.0089	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00884	0.00884	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Fludarabine—lymphatic system cancer	0.00882	0.00882	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00853	0.00853	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Bleomycin—lymphatic system cancer	0.0085	0.0085	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00843	0.00843	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Teniposide—lymphatic system cancer	0.00835	0.00835	CcSEcCtD
Acetohydroxamic Acid—Malaise—Bleomycin—lymphatic system cancer	0.00829	0.00829	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Carmustine—lymphatic system cancer	0.00815	0.00815	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Vincristine—lymphatic system cancer	0.00778	0.00778	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Bleomycin—lymphatic system cancer	0.00773	0.00773	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Mitoxantrone—lymphatic system cancer	0.00757	0.00757	CcSEcCtD
Acetohydroxamic Acid—Tremor—Carmustine—lymphatic system cancer	0.00752	0.00752	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Carmustine—lymphatic system cancer	0.00742	0.00742	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Teniposide—lymphatic system cancer	0.0074	0.0074	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Fludarabine—lymphatic system cancer	0.00734	0.00734	CcSEcCtD
Acetohydroxamic Acid—Rash—Teniposide—lymphatic system cancer	0.00734	0.00734	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Teniposide—lymphatic system cancer	0.00734	0.00734	CcSEcCtD
Acetohydroxamic Acid—Headache—Teniposide—lymphatic system cancer	0.00729	0.00729	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Bleomycin—lymphatic system cancer	0.00715	0.00715	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00713	0.00713	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Vincristine—lymphatic system cancer	0.00708	0.00708	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00692	0.00692	CcSEcCtD
Acetohydroxamic Acid—Nausea—Teniposide—lymphatic system cancer	0.00692	0.00692	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Mitoxantrone—lymphatic system cancer	0.0069	0.0069	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Carmustine—lymphatic system cancer	0.00681	0.00681	CcSEcCtD
Acetohydroxamic Acid—Malaise—Mitoxantrone—lymphatic system cancer	0.00673	0.00673	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Bleomycin—lymphatic system cancer	0.00652	0.00652	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Fludarabine—lymphatic system cancer	0.00651	0.00651	CcSEcCtD
Acetohydroxamic Acid—Rash—Fludarabine—lymphatic system cancer	0.00645	0.00645	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Fludarabine—lymphatic system cancer	0.00645	0.00645	CcSEcCtD
Acetohydroxamic Acid—Headache—Fludarabine—lymphatic system cancer	0.00641	0.00641	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Mitoxantrone—lymphatic system cancer	0.00633	0.00633	CcSEcCtD
Acetohydroxamic Acid—Lethargy—Methotrexate—lymphatic system cancer	0.0063	0.0063	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Mitoxantrone—lymphatic system cancer	0.00628	0.00628	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Carmustine—lymphatic system cancer	0.00624	0.00624	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00618	0.00618	CcSEcCtD
Acetohydroxamic Acid—Nausea—Fludarabine—lymphatic system cancer	0.00608	0.00608	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Vincristine—lymphatic system cancer	0.00596	0.00596	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Mitoxantrone—lymphatic system cancer	0.0058	0.0058	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Carmustine—lymphatic system cancer	0.00569	0.00569	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00565	0.00565	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Vincristine—lymphatic system cancer	0.00544	0.00544	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.0054	0.0054	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Carmustine—lymphatic system cancer	0.0054	0.0054	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Vincristine—lymphatic system cancer	0.00539	0.00539	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Bleomycin—lymphatic system cancer	0.00538	0.00538	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00529	0.00529	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Mitoxantrone—lymphatic system cancer	0.00525	0.00525	CcSEcCtD
Acetohydroxamic Acid—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00511	0.00511	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00502	0.00502	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Bleomycin—lymphatic system cancer	0.00477	0.00477	CcSEcCtD
Acetohydroxamic Acid—Depression—Methotrexate—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Acetohydroxamic Acid—Rash—Bleomycin—lymphatic system cancer	0.00473	0.00473	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Bleomycin—lymphatic system cancer	0.00473	0.00473	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Carmustine—lymphatic system cancer	0.0047	0.0047	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Methotrexate—lymphatic system cancer	0.00468	0.00468	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Vincristine—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Acetohydroxamic Acid—Nausea—Bleomycin—lymphatic system cancer	0.00446	0.00446	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Mitoxantrone—lymphatic system cancer	0.00437	0.00437	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Carmustine—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Acetohydroxamic Acid—Rash—Carmustine—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Carmustine—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Acetohydroxamic Acid—Headache—Carmustine—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Vincristine—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Acetohydroxamic Acid—Rash—Vincristine—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Vincristine—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Acetohydroxamic Acid—Headache—Vincristine—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Acetohydroxamic Acid—Nausea—Carmustine—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Mitoxantrone—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Acetohydroxamic Acid—Rash—Mitoxantrone—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Acetohydroxamic Acid—Headache—Mitoxantrone—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Methotrexate—lymphatic system cancer	0.00377	0.00377	CcSEcCtD
Acetohydroxamic Acid—Nausea—Vincristine—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Acetohydroxamic Acid—Nausea—Mitoxantrone—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Methotrexate—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Acetohydroxamic Acid—Malaise—Methotrexate—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Methotrexate—lymphatic system cancer	0.00313	0.00313	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Methotrexate—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Methotrexate—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Methotrexate—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Methotrexate—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Methotrexate—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Methotrexate—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Acetohydroxamic Acid—Rash—Methotrexate—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Methotrexate—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Acetohydroxamic Acid—Headache—Methotrexate—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Acetohydroxamic Acid—Nausea—Methotrexate—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
